Post-approval studies (Phase 4)Study completedNCT00858104What this trial is testingPercutaneous Laser Ablation in Benign Thyroid Nodules.Long Term ResultsWho this might be right forThyroid Nodule Elesta S.R.L. 200
Not applicableEnrolling By InvitationNCT06834204What this trial is testingAdvancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer SurvivorsWho this might be right forCancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more Rutgers, The State University of New Jersey 266
Not applicableStudy completedNCT02565706What this trial is testingOnline WIC Nutrition Education to Promote Farmers' Market Fruit and Vegetable Purchases and ConsumptionWho this might be right forCardiovascular DiseasesCancerType 2 Diabetes+1 more William Paterson University of New Jersey 744
Early research (Phase 1)Looking for participantsNCT05005403What this trial is testingStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanWho this might be right forNon-Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMicro Satellite Stable Colorectal Cancer+4 more AbbVie
Large-scale testing (Phase 3)UnknownNCT01622361What this trial is testingPremenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast CancerWho this might be right forBreast Cancer Asan Medical Center 290
Not applicableStudy completedNCT04560270What this trial is testingCIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic CancerWho this might be right forPancreatic CancerCirculating Tumor DNAKRAS Mutation-Related Tumors Poitiers University Hospital 69
Testing effectiveness (Phase 2)Study completedNCT02491983What this trial is testingPalbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast CancerWho this might be right forMetastatic Breast Cancer MedSIR 486
Testing effectiveness (Phase 2)Ended earlyNCT00516841What this trial is testingA Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal CancerWho this might be right forOvarian CancerPeritoneal Neoplasms Facet Biotech 16
Not applicableNot Yet RecruitingNCT07693894What this trial is testingDISARM Clinical Study B: Evaluation of Innovative Ovarian Cancer Biomarker AssaysWho this might be right forOvarian Cancer National and Kapodistrian University of Athens 2,080
Early research (Phase 1)Study completedNCT00603356What this trial is testingPhase I Study of OSI-930 and Erlotinib in Cancer TumorsWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 60
Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Very early researchUnknownNCT05180851What this trial is testingSafety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical StudyWho this might be right forHead and Neck CancerMelanomaBreast Cancer+4 more Shanghai Fengxian District Central Hospital 28
Early research (Phase 1)Ended earlyNCT04893551What this trial is testingTilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) ParticipantsWho this might be right forOvarian Neoplasms BerGenBio ASA 16
Testing effectiveness (Phase 2)Study completedNCT00499486What this trial is testingSirolimus in Treating Patients With Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 47
Early research (Phase 1)Study completedNCT01665183What this trial is testingPh 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic MelanomaWho this might be right forCutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors Polaris Group 8
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816666What this trial is testingTorvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian CancerWho this might be right forPlatinum-sensitive Relapsed Epithelial Ovarian CancerPlatinum-sensitive Relapsed Fallopian Tube CancerPlatinum-sensitive Relapsed Primary Peritoneal Cancer AstraZeneca 600
Early research (Phase 1)WithdrawnNCT04270929What this trial is testingPressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic CarcinomaWho this might be right forPancreatic Adenocarcinoma Roger Williams Medical Center
Early research (Phase 1)Active Not RecruitingNCT07038369What this trial is testingATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsWho this might be right forAdvanced Solid TumorsBreast CancerBreast Carcinoma+24 more Atavistik Bio, Inc 134
Not applicableStudy completedNCT01310569What this trial is testingSubcutaneous Adipose Tissue in Cases With Polycystic Ovarian SyndromeWho this might be right forPolycystic Ovary Syndrome Gulhane School of Medicine 52
Early research (Phase 1)UnknownNCT02975141What this trial is testingAfatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer PD Dr. med. Volker Heinemann 12